Transformation of amyloid β(1–40) oligomers into fibrils is characterized by a major change in secondary structure (original) (raw)

References

1. Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81:678–699
   Article PubMed CAS Google Scholar
2. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486–489
   Article PubMed CAS Google Scholar
3. Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB (1993) Characterization of beta-amyloid peptide from human cerebrospinal fluid. J Neurochem 61:1965–1968
   Article PubMed CAS Google Scholar
4. Wilquet V, De Strooper B (2004) Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol 14:582–588
   Article PubMed CAS Google Scholar
5. Xu Y, Shen J, Luo X, Zhu W, Chen K, Ma J, Jiang H (2005) Conformational transition of amyloid beta-peptide. Proc Natl Acad Sci USA 102:5403–5407
   Article PubMed CAS Google Scholar
6. Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN (1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45:373–379
   PubMed CAS Google Scholar
7. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14:837–842
   Article PubMed CAS Google Scholar
8. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352–357
   Article PubMed CAS Google Scholar
9. Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, Head E, Hall J, Glabe C (2009) Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem 284:4230–4237
   Article PubMed CAS Google Scholar
10. Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185
    Article PubMed CAS Google Scholar
11. De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN, Bigio EH, Jerecic J, Acton PJ, Shughrue PJ, Chen-Dodson E, Kinney GG, Klein WL (2008) Alzheimer’s disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers. Neurobiol Aging 29:1334–1347
    Article PubMed Google Scholar
12. De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL (2007) Abeta oligomers induce neuronal oxidative stress through an _N_-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590–11601
    Article PubMed Google Scholar
13. Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, Viola KL, Klein WL, Stine WB, Krafft GA, Trommer BL (2002) Soluble oligomers of beta amyloid (1–42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924:133–140
    Article PubMed CAS Google Scholar
14. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448–6453
    Article PubMed CAS Google Scholar
15. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27:796–807
    Article PubMed CAS Google Scholar
16. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356
    Article PubMed CAS Google Scholar
17. Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S, Elliott JI, Van Nostrand WE, Smith SO (2010) Structural conversion of neurotoxic amyloid-beta(1–42) oligomers to fibrils. Nat Struct Mol Biol 17:561–567
    Article PubMed CAS Google Scholar
18. Yu L, Edalji R, Harlan JE, Holzman TF, Lopez AP, Labkovsky B, Hillen H, Barghorn S, Ebert U, Richardson PL, Miesbauer L, Solomon L, Bartley D, Walter K, Johnson RW, Hajduk PJ, Olejniczak ET (2009) Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry 48:1870–1877
    Article PubMed CAS Google Scholar
19. Habicht G, Haupt C, Friedrich RP, Hortschansky P, Sachse C, Meinhardt J, Wieligmann K, Gellermann GP, Brodhun M, Gotz J, Halbhuber KJ, Rocken C, Horn U, Fandrich M (2007) Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc Natl Acad Sci USA 104:19232–19237
    Article PubMed CAS Google Scholar
20. Cerf E, Sarroukh R, Tamamizu-Kato S, Breydo L, Derclaye S, Dufrene YF, Narayanaswami V, Goormaghtigh E, Ruysschaert JM, Raussens V (2009) Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide. Biochem J 421:415–423
    Article PubMed CAS Google Scholar
21. Eckert A, Hauptmann S, Scherping I, Meinhardt J, Rhein V, Drose S, Brandt U, Fandrich M, Muller WE, Gotz J (2008) Oligomeric and fibrillar species of beta-amyloid (Aβ 42) both impair mitochondrial function in P301L tau transgenic mice. J Mol Med 86:1255–1267
    Article PubMed CAS Google Scholar
22. Come JH, Fraser PE, Lansbury PT Jr (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 90:5959–5963
    Article PubMed CAS Google Scholar
23. Necula M, Kayed R, Milton S, Glabe CG (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282:10311–10324
    Article PubMed CAS Google Scholar
24. Wetzel R (2006) Kinetics and thermodynamics of amyloid fibril assembly. Acc Chem Res 39:671–679
    Article PubMed CAS Google Scholar
25. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R (2002) A structural model for Alzheimer’s beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99:16742–16747
    Article PubMed CAS Google Scholar
26. Balbach JJ, Petkova AT, Oyler NA, Antzutkin ON, Gordon DJ, Meredith SC, Tycko R (2002) Supramolecular structure in full-length Alzheimer’s beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys J 83:1205–1216
    Article PubMed CAS Google Scholar
27. Schmidt M, Sachse C, Richter W, Xu C, Fandrich M, Grigorieff N (2009) Comparison of Alzheimer Abeta(1–40) and Abeta(1–42) amyloid fibrils reveals similar protofilament structures. Proc Natl Acad Sci USA 106:19813–19818
    PubMed CAS Google Scholar
28. Teplow DB, Lazo ND, Bitan G, Bernstein S, Wyttenbach T, Bowers MT, Baumketner A, Shea JE, Urbanc B, Cruz L, Borreguero J, Stanley HE (2006) Elucidating amyloid beta-protein folding and assembly: a multidisciplinary approach. Acc Chem Res 39:635–645
    Article PubMed CAS Google Scholar
29. Chen D, Martin ZS, Soto C, Schein CH (2009) Computational selection of inhibitors of Abeta aggregation and neuronal toxicity. Bioorg Med Chem 17:5189–5197
    Article PubMed CAS Google Scholar
30. LeVine H III (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309:274–284
    Article PubMed CAS Google Scholar
31. Goormaghtigh E, Raussens V, Ruysschaert JM (1999) Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes. Biochim Biophys Acta 1422:105–185
    PubMed CAS Google Scholar
32. Goormaghtigh E, Cabiaux V, Ruysschaert JM (1990) Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur J Biochem 193:409–420
    Article PubMed CAS Google Scholar
33. Mastrangelo IA, Ahmed M, Sato T, Liu W, Wang C, Hough P, Smith SO (2006) High-resolution atomic force microscopy of soluble Abeta42 oligomers. J Mol Biol 358:106–119
    Article PubMed CAS Google Scholar
34. Chirgadze YN, Nevskaya NA (1976) Infrared spectra and resonance interaction of amide-I vibration of the antiparallel-chain pleated sheet. Biopolymers 15:607–625
    Article PubMed CAS Google Scholar
35. Krimm S, Bandekar J (1986) Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv Protein Chem 38:181–364
    Article PubMed CAS Google Scholar
36. Miyazawa T, Blout ER (1961) The Infrared spectra of polypeptides in various conformations: amide I and II bands. J Am Chem Soc 83(3):712–719
    Article CAS Google Scholar
37. Oberg KA, Ruysschaert JM, Goormaghtigh E (2004) The optimization of protein secondary structure determination with infrared and circular dichroism spectra. Eur J Biochem 271:2937–2948
    Article PubMed CAS Google Scholar
38. Kubelka J, Keiderling TA (2001) Differentiation of beta-sheet-forming structures: ab initio-based simulations of IR absorption and vibrational CD for model peptide and protein beta-sheets. J Am Chem Soc 123:12048–12058
    Article PubMed CAS Google Scholar
39. Zandomeneghi G, Krebs MR, McCammon MG, Fandrich M (2004) FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils. Protein Sci 13:3314–3321
    Article PubMed CAS Google Scholar
40. Hoyer W, Gronwall C, Jonsson A, Stahl S, Hard T (2008) Stabilization of a beta-hairpin in monomeric Alzheimer’s amyloid-beta peptide inhibits amyloid formation. Proc Natl Acad Sci USA 105:5099–5104
    Article PubMed CAS Google Scholar
41. Petkova AT, Yau WM, Tycko R (2006) Experimental constraints on quaternary structure in Alzheimer’s beta-amyloid fibrils. Biochemistry 45:498–512
    Article PubMed CAS Google Scholar
42. Bitan G, Fradinger EA, Spring SM, Teplow DB (2005) Neurotoxic protein oligomers—what you see is not always what you get. Amyloid 12:88–95
    Article PubMed Google Scholar
43. Tomaselli S, Esposito V, Vangone P, van Nuland NA, Bonvin AM, Guerrini R, Tancredi T, Temussi PA, Picone D (2006) The alpha-to-beta conformational transition of Alzheimer’s Abeta-(1–42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. Chembiochem 7:257–267
    Article PubMed CAS Google Scholar
44. Fraser PE, Nguyen JT, Surewicz WK, Kirschner DA (1991) pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J 60:1190–1201
    Article PubMed CAS Google Scholar
45. Peralvarez-Marin A, Mateos L, Zhang C, Singh S, Cedazo-Minguez A, Visa N, Morozova-Roche L, Graslund A, Barth A (2009) Influence of residue 22 on the folding, aggregation profile, and toxicity of the Alzheimer’s amyloid beta peptide. Biophys J 97:277–285
    Article PubMed CAS Google Scholar
46. Walsh DM, Selkoe DJ (2007) Aβ oligomers—a decade of discovery. J Neurochem 101:1172–1184
    Article PubMed CAS Google Scholar
47. Dasilva KA, Shaw JE, McLaurin J (2009) Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention. Exp Neurol 223(2):311–321
    Article PubMed Google Scholar
48. Necula M, Breydo L, Milton S, Kayed R, van der Veer WE, Tone P, Glabe CG (2007) Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry 46:8850–8860
    Article PubMed CAS Google Scholar
49. Ferrao-Gonzales AD, Robbs BK, Moreau VH, Ferreira A, Juliano L, Valente AP, Almeida FC, Silva JL, Foguel D (2005) Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. J Biol Chem 280:34747–34754
    Article PubMed CAS Google Scholar
50. Garzon-Rodriguez W, Sepulveda-Becerra M, Milton S, Glabe CG (1997) Soluble amyloid Abeta-(1–40) exists as a stable dimer at low concentrations. J Biol Chem 272:21037–21044
    Article PubMed CAS Google Scholar
51. Liao MQ, Tzeng YJ, Chang LY, Huang HB, Lin TH, Chyan CL, Chen YC (2007) The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides. FEBS Lett 581:1161–1165
    Article PubMed CAS Google Scholar
52. Khurana R, Fink AL (2000) Do parallel beta-helix proteins have a unique fourier transform infrared spectrum? Biophys J 78:994–1000
    Article PubMed CAS Google Scholar
53. Fabian H, Gast K, Laue M, Misselwitz R, Uchanska-Ziegler B, Ziegler A, Naumann D (2008) Early stages of misfolding and association of beta2-microglobulin: insights from infrared spectroscopy and dynamic light scattering. Biochemistry 47:6895–6906
    Article PubMed CAS Google Scholar
54. Natalello A, Prokorov VV, Tagliavini F, Morbin M, Forloni G, Beeg M, Manzoni C, Colombo L, Gobbi M, Salmona M, Doglia SM (2008) Conformational plasticity of the Gerstmann–Straussler–Scheinker disease peptide as indicated by its multiple aggregation pathways. J Mol Biol 381:1349–1361
    Article PubMed CAS Google Scholar
55. Lim YA, Rhein V, Baysang G, Meier F, Poljak A, Raftery MJ, Guilhaus M, Ittner LM, Eckert A, Gotz J (2010) Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics 10:1621–1633
    Article PubMed CAS Google Scholar
56. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507–511
    Article PubMed CAS Google Scholar
57. Ravault S, Soubias O, Saurel O, Thomas A, Brasseur R, Milon A (2005) Fusogenic Alzheimer’s peptide fragment Abeta (29–42) in interaction with lipid bilayers: secondary structure, dynamics, and specific interaction with phosphatidyl ethanolamine polar heads as revealed by solid-state NMR. Protein Sci 14:1181–1189
    Article PubMed CAS Google Scholar

Download references